Antihair Export Market Intelligence: India's 5 Suppliers Shipping to 5 Countries — TransData Nexus 2026

Q: Who are the top antihair exporters from India?

The top antihair exporters from India are: 1. LAKH BRANDING PRIVATE LIMITED — $2.3K (65.4% market share). Together they account for 65.4% of India's total antihair export value.

Q: What is the total export value of antihair from India?

The total export value of antihair from India is $3.6K USD, recorded across 47 shipment transactions from 5 active exporters to 5 destination countries. The average shipment value is $76.

Q: Which countries import antihair from India?

India exports antihair to 5 countries worldwide. The top importing countries are: SOUTH KOREA (65.4% share, $2.3K), SOUTH AFRICA (15.3% share, $546), CZECH REPUBLIC (7.5% share, $268), MALDIVES (6.2% share, $223), IRAQ (5.5% share, $197). These five markets account for 100.0% of total export value.

Q: What is the HS code for antihair exports from India?

The primary HS code for antihair exports from India is 30049011. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of antihair exports from India?

The average unit price for antihair exports from India is $3.89 USD per unit, with prices ranging from $0.04 to $30.35 depending on formulation, packaging, and order volume. The total market is valued at $3.6K across 47 shipments.

Q: Which ports handle antihair exports from India?

The primary ports for antihair exports from India are DELHI AIR (38.3% of shipments), DELHI AIR CARGO ACC (INDEL4) (34.0% of shipments), Delhi Air (8.5% of shipments), Delhi Air Cargo (6.4% of shipments), TUGLAKABAD ICD (4.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of antihair?

India is one of the world's leading exporters of antihair due to its large base of 5 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports antihair to 5 countries, demonstrating 3% global market coverage.

Q: What certifications do Indian antihair exporters need?

Indian antihair exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import antihair from India?

There are 11 registered buyers importing antihair from India, spread across 5 countries. The repeat buyer rate is 72.7%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top antihair supplier from India?

LAKH BRANDING PRIVATE LIMITED is the leading antihair exporter from India with a market share of 65.4% and total export value of $2.3K across 41 shipments. The top 5 suppliers together control 65.4% of total export value.

Suresh Sormare

Antihair

India Pharmaceutical Trade Intelligence

$3.6K5 Suppliers5 CountriesHS 30049011

ExportsIndia → SOUTH KOREA65.4%India → SOUTH AFRICA15.3%

Antihair Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Antihair to the World

Between 2022 and 2026, India exported $3.6K worth of antihair across 47 verified shipments to 5 countries — covering 3% of world markets in the Specialty Formulations segment. The largest destination is SOUTH KOREA (65.4%). LAKH BRANDING PRIVATE LIMITED leads with a 65.4% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Antihair export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Antihair export data snapshot — $3.6K · 5 exporters · 5 countriesTransData Nexus · Indian Customs Data

Top Antihair Exporters from India

5 active exporters · Ranked by export value

View all 5 →

Top Antihair Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	LAKH BRANDING PRIVATE LIMITED	$2.3K	41	1	65.4%

Based on customs records from 2022 through early 2026, India's antihair export market is led by LAKH BRANDING PRIVATE LIMITED, which holds a share of all antihair exports — the largest of any single manufacturer over this period. The top 5 suppliers together account for of total export value, reflecting a concentrated supplier landscape among the 5 active exporters. Each supplier handles an average of , indicating selective, specialised distribution patterns.

Top Countries Importing Antihair from India

5 destination markets · Ranked by import value

All 5 countries →

Top Countries Importing Antihair from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	SOUTH KOREA	$2.3K	65.4%
2	SOUTH AFRICA	$546	15.3%
3	CZECH REPUBLIC	$268	7.5%
4	MALDIVES	$223	6.2%
5	IRAQ	$197	5.5%

SOUTH KOREA is India's largest antihair export destination, absorbing 65.4% of total exports worth $2.3K. The top 5 importing countries — SOUTH KOREA, SOUTH AFRICA, CZECH REPUBLIC, MALDIVES, IRAQ — together account for 100.0% of India's total antihair export value. The remaining 0 destination countries collectively receive the other 0.0%, indicating a focused distribution strategy targeting key markets.

Regulatory Landscape — Antihair

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, "Antihair" has not been approved by the U.S. Food and Drug Administration (FDA) under an Abbreviated New Drug Application (ANDA). A review of the FDA's Orange Book, which lists approved drug products, confirms the absence of "Antihair" or its generic equivalents. Consequently, the product is not authorized for marketing in the United States.

The FDA mandates that all human drug imports meet stringent standards for quality, safety, and efficacy. This includes compliance with registration, listing, and labeling requirements, as well as adherence to current good manufacturing practices (cGMPs). Importers must ensure that foreign establishments hold the necessary approvals, such as a New Drug Application (NDA) or ANDA, for their products. Failure to meet these criteria can result in detention without physical examination under FDA import alerts. As of March 2026, there are no specific import alerts related to "Antihair" from India. However, the absence of FDA approval precludes its legal importation and distribution in the U.S. market.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), pharmaceutical products require marketing authorization before they can be marketed. This process involves a comprehensive evaluation of the product's quality, safety, and efficacy. The European Medicines Agency (EMA) oversees this process within the EU, while the Medicines and Healthcare products Regulatory Agency (MHRA) is responsible in the UK. As of March 2026, there is no public record of "Antihair" receiving marketing authorization from either the EMA or the MHRA.

Manufacturers intending to export pharmaceutical products to the EU and UK must comply with Good Manufacturing Practice (GMP) standards. These standards ensure that products are consistently produced and controlled according to quality standards. Compliance with GMP is a prerequisite for obtaining marketing authorization and is subject to regular inspections by regulatory authorities.

3WHO Essential Medicines & Global Standards

The World Health Organization (WHO) maintains the Model List of Essential Medicines, which identifies medications considered essential for addressing public health needs. As of the latest edition, "Antihair" is not included in this list. Additionally, there is no record of "Antihair" being prequalified by the WHO, a process that assesses the quality, safety, and efficacy of medicinal products.

Pharmaceutical products are also expected to meet standards set forth in various pharmacopoeias, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Compliance with these standards ensures the quality and consistency of pharmaceutical products.

4India Regulatory Classification

In India, the Central Drugs Standard Control Organization (CDSCO) classifies drugs into various schedules under the Drugs and Cosmetics Act. The specific classification of "Antihair" would determine its regulatory requirements, including prescription status and sale restrictions. As of March 2026, there is no publicly available information regarding the specific schedule classification of "Antihair."

The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of pharmaceutical products in India. If "Antihair" falls under the purview of the Drug Price Control Order (DPCO), it would be subject to price ceilings established by the NPPA. However, there is no publicly available information indicating that "Antihair" is subject to such pricing controls.

For the export of pharmaceutical products, Indian manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT). This certificate ensures that the product complies with the regulatory requirements of the importing country.

5Patent & Exclusivity Status

The patent status of "Antihair" is a critical factor in determining its market exclusivity and the potential for generic competition. As of March 2026, there is no publicly available information regarding active patents or exclusivity rights associated with "Antihair." The absence of patent protection could facilitate the entry of generic versions into the market, subject to regulatory approvals.

6Recent Industry Developments

In the past 12 months, several developments have impacted the pharmaceutical industry:

1. API Price Fluctuations: In June 2025, the Indian government reported significant volatility in the prices of Active Pharmaceutical Ingredients (APIs), prompting the NPPA to monitor and regulate pricing to ensure affordability and availability.

2. Regulatory Approvals: In September 2025, the CDSCO approved several new generic drugs, enhancing the availability of affordable medications in the Indian market.

3. Policy Changes: In December 2025, the DGFT introduced new guidelines for the export of pharmaceutical products, emphasizing compliance with international quality standards to boost global competitiveness.

These developments underscore the dynamic nature of the pharmaceutical regulatory landscape and the importance of staying informed about changes that may affect market access and compliance requirements.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Antihair

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, often referred to as the "pharmacy of the world," heavily relies on China for Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs). Approximately 70% of critical KSMs and APIs are imported, with China being the predominant supplier. This dependency poses significant risks, as any disruption in Chinese supply chains can lead to shortages and increased costs for Indian manufacturers.

Recent disruptions have highlighted these vulnerabilities. In February 2025, the FDA issued warning letters to API manufacturers in China and India for significant deviations from current Good Manufacturing Practice (cGMP). These violations included failures in quality control, data integrity, and facility maintenance, leading to the classification of their APIs as "adulterated" under the Federal Food, Drug, and Cosmetic Act. Such regulatory actions can cause supply interruptions, emphasizing the need for diversified sourcing strategies.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters account for 65.4% of "Antihair" exports from India, with LAKH BRANDING PRIVATE LIMITED alone contributing 65.4%. This high concentration exposes the supply chain to significant risks if any of these key suppliers face operational challenges.

To mitigate such risks, the Indian government introduced the Production Linked Incentive (PLI) scheme in 2021, aiming to bolster domestic API and KSM production. By November 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and Clavulanic Acid, which had not been produced domestically for over two decades. While these initiatives are steps toward reducing import dependence, the current supplier concentration remains a concern.

Access Complete Antihair Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 47 transactions across 5 markets.

Request Demo View Pricing

Frequently Asked Questions — Antihair Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top antihair exporters from India?

The leading antihair exporters from India are LAKH BRANDING PRIVATE LIMITED. LAKH BRANDING PRIVATE LIMITED leads with 65.4% market share ($2.3K). The top 5 suppliers together control 65.4% of total export value.

What is the total export value of antihair from India?

The total export value of antihair from India is $3.6K, recorded across 47 shipments from 5 active exporters to 5 countries. The average shipment value is $76.

Which countries import antihair from India?

India exports antihair to 5 countries. The top importing countries are SOUTH KOREA (65.4%), SOUTH AFRICA (15.3%), CZECH REPUBLIC (7.5%), MALDIVES (6.2%), IRAQ (5.5%), which together account for 100.0% of total export value.

What is the HS code for antihair exports from India?

The primary HS code for antihair exports from India is 30049011. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Antihair

Antihair

How India Exports Antihair to the World

Top Antihair Exporters from India

Top Countries Importing Antihair from India

Quick Facts

Related Specialty Formulations

Related Analysis

Need Details?

Regulatory Landscape — Antihair

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Antihair

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Antihair Trade Intelligence

Frequently Asked Questions — Antihair Exports from India

Who are the top antihair exporters from India?

What is the total export value of antihair from India?

Which countries import antihair from India?

What is the HS code for antihair exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of antihair exports from India?

Which ports handle antihair exports from India?

Why is India a leading exporter of antihair?

What certifications do Indian antihair exporters need?

How many buyers import antihair from India?

What is the market share of the top antihair exporter from India?

Analysis Methodology